Seattle Genetics, Inc. (SGEN): Price and Financial Metrics
Seattle Genetics, Inc. (SGEN)
Today's Latest Price: $192.34 USD
Updated Oct 29 4:00pm
Add SGEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SGEN Stock Summary
- Seagen Inc's market capitalization of $33,903,241,407 is ahead of 94.38% of US-listed equities.
- With a one year PEG ratio of 841.94, Seagen Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.05% of US stocks.
- With a price/sales ratio of 33.38, Seagen Inc has a higher such ratio than 94.62% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Seagen Inc are BGNE, MRVL, EA, XLNX, and CDNS.
- SGEN's SEC filings can be seen here. And to visit Seagen Inc's official web site, go to www.seattlegenetics.com.
SGEN Stock Price Chart Interactive Chart >
SGEN Price/Volume Stats
| Current price | $192.34 | 52-week high | $213.94 |
| Prev. close | $194.85 | 52-week low | $90.57 |
| Day low | $189.02 | Volume | 787,300 |
| Day high | $196.10 | Avg. volume | 1,115,249 |
| 50-day MA | $180.09 | Dividend yield | N/A |
| 200-day MA | $150.36 | Market Cap | 33.47B |
Seattle Genetics, Inc. (SGEN) Company Bio
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. The company was founded in 1998 and is based in Bothell, Washington.
Loading social stream, please wait...